Financial results: Bioxyne; Melodiol Global Health; Emyria; Zelira; Elixinol; Wellnex Life; Argent BioPharma by Steve Jones May 1, 2024May 1, 2024 Revenue generated by Breathe Life Sciences (BLS) slipped to A$1.7 million in Q3 FY24 with parent […]
‘Protectionism doesn’t work’, Biortica chief warns as industry urged to take collaborative approach on imports by Steve Jones May 1, 2024May 1, 2024
Cann Group takes steps to resume ASX trading as Q3 revenues tumble and cash flow worsens by Steve Jones April 30, 2024April 30, 2024
Althea makes further savings as cost-cutting program continues by Steve Jones April 30, 2024April 30, 2024
Record harvest and softer revenue hit ECS Botanics’ Q3 cash flow by Steve Jones April 29, 2024April 29, 2024
Vitura wins injunction to prevent tech partner switching off CanView system by Steve Jones April 26, 2024May 2, 2024
Dolphins’ Alternaleaf blackout piles more pressure on Montu amid TGA legal action by Steve Jones April 24, 2024April 24, 2024
‘Desperately needed’ export reforms back on agenda in New Zealand by Steve Jones April 23, 2024April 24, 2024
Vitura seeks legal intervention after tech partner threatens to derail CanView operations within days by Steve Jones April 23, 2024April 26, 2024
TGA issues quality warning and prepares to begin testing after reports of ‘questionable’ products by Steve Jones April 19, 2024April 23, 2024
